AAAAAA
Results: 201-225/314
Authors:
HIRSCHL RB
PARENT A
TOOLEY R
SHAFFER T
WOLFSON M
BARTLETT RH
Citation: Rb. Hirschl et al., LUNG MANAGEMENT WITH PERFLUOROCARBON LIQUID VENTILATION IMPROVES PULMONARY-FUNCTION AND GAS-EXCHANGE DURING EXTRACORPOREAL MEMBRANE-OXYGENATION (ECMO), Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1389-1396
Authors:
FOX WW
COX C
WEIS C
WOLFSON MR
SHAFFER TH
Citation: Ww. Fox et al., NEONATAL ENDOTRACHEAL-TUBES - VARIATION IN AIRWAY-RESISTANCE WITH DIFFERENT PERFLUOROCHEMICAL LIQUIDS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1397-1402
Authors:
FREZARD F
SANTAELLA C
VIERLING P
RIESS JG
Citation: F. Frezard et al., FLUORINATED PHOSPHOLIPID-BASED VESICLES AS POTENTIAL-DRUG CARRIERS - ENCAPSULATION SUSTAINING OF DRUGS AND STABILITY IN HUMAN SERUM/, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1403-1408
Authors:
WOLFSON MR
STERN RG
KECHNER N
SEKINS KM
SHAFFER TH
Citation: Mr. Wolfson et al., UTILITY OF A PERFLUOROCHEMICAL LIQUID FOR PULMONARY DIAGNOSTIC-IMAGING, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1409-1420
Authors:
SANCHEZ V
ZARIF L
GREINER J
RIESS JG
CIPPOLINI S
BRUNETON JN
Citation: V. Sanchez et al., NOVEL INJECTABLE FLUORINATED CONTRAST AGENTS WITH ENHANCED RADIOPACITY, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1421-1428
Authors:
HANNA G
SAEWERT D
SHORR J
FLAIM K
LEESE P
KOPPERMAN M
WOLF G
Citation: G. Hanna et al., PRECLINICAL AND CLINICAL-STUDIES ON LYMPH-NODE IMAGING USING PERFLUBRON EMULSION, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1429-1439
Authors:
IKOMI F
HANNA G
SCHMIDSCHONBEIN GW
Citation: F. Ikomi et al., INTRACELLULAR AND EXTRACELLULAR TRANSPORT OF PERFLUORO CARBON EMULSION FROM SUBCUTANEOUS TISSUE TO REGIONAL LYMPHATICS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1441-1447
Authors:
GUO QZ
MATTREY RF
GUCLU C
BUXTON RB
NALCIOGLU O
Citation: Qz. Guo et al., MONITORING OF PO(2) BY SPIN-SPIN RELAXATION RATE 1 T-2 OF F-19 IN A RABBIT ABSCESS MODEL/, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1449-1454
Authors:
VOIGLIO EJ
ZARIF L
GORRY F
KRAFFT MP
MARGONARI J
DUBERNARD JM
RIESS JG
Citation: Ej. Voiglio et al., NORMOTHERMIC PRESERVATION OF MULTIPLE ORGAN BLOCKS WITH A NEW PERFLUOROOCTYL BROMIDE EMULSION, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1455-1461
Authors:
BRASILE L
DELVECCHIO P
AMYOT K
HAISCH C
CLARKE J
Citation: L. Brasile et al., ORGAN PRESERVATION WITHOUT EXTREME HYPOTHERMIA USING AN OXYGENT(TM) SUPPLEMENTED PERFUSATE, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1463-1468
Authors:
BRASILE L
DELVECCHIO P
RUDOFSKY U
HAISCH C
CLARKE J
Citation: L. Brasile et al., POSTMORTEM ORGAN SALVAGE USING AN OXYGENT(TM) SUPPLEMENTED PERFUSATE, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1469-1475
Authors:
EILENBERG SS
TARTAR VM
MATTREY RF
Citation: Ss. Eilenberg et al., REDUCING MAGNETIC-SUSCEPTIBILITY DIFFERENCES USING LIQUID FLUOROCARBON PADS (SAT PAD(TM)) - RESULTS WITH SPECTRAL PRESATURATION OF FAT, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1477-1483
Authors:
ZARIF L
RIESS JG
PUCCI B
GUEDJ C
PAVIA AA
Citation: L. Zarif et al., DOUBLE-TAILED PERFLUOROALKYLATED GLYCOLIPIDS AS COMPONENTS FOR DRUG-DELIVERY AND TARGETING SYSTEMS - PRELIMINARY BIOCOMPATIBILITY RESULTS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1485-1490
Authors:
BAKER KG
WRIGLEY R
SAUNDERS HB
MATTREY RF
Citation: Kg. Baker et al., EFFICACY OF IMAGENT(R) BP AT 1.5ML KG IN A RABBIT LIVER-TUMOR MODEL/, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1491-1499
Authors:
STEINBACH GC
BAKER KG
LIM GL
MATTREY RF
ARELLANO RS
Citation: Gc. Steinbach et al., THE USE OF IMAGENT(R)BP AS A BLOOD-POOL CONTRAST AGENT TO VISUALIZE AND QUANTITATE LIVER-TUMOR BURDEN, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1501-1509
Authors:
FLAIM SF
HAZARD DR
HOGAN J
PETERS RM
Citation: Sf. Flaim et al., CHARACTERIZATION AND MECHANISM OF SIDE-EFFECTS OF OXYGENT(TM) HT (HIGHLY CONCENTRATED FLUOROCARBON EMULSION) IN SWINE, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1511-1515
Authors:
RIESS JG
Citation: Jg. Riess, 3RD OF 3 SPECIAL ISSUES FROM 5TH INTERNATIONAL-SYMPOSIUM-ON-BLOOD-SUBSTITUTES, SAN-DIEGO, CALIFORNIA, USA - MARCH 17-20, 1993, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 180000017-180000018
Authors:
HESS JR
MACDONALD VW
GOMEZ CS
COPPES V
Citation: Jr. Hess et al., INCREASED VASCULAR-RESISTANCE WITH HEMOGLOBIN-BASED OXYGEN CARRIERS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 361-372
Authors:
ALAYASH AI
RYAN BAB
FRATANTONI JC
CASHON RE
Citation: Ai. Alayash et al., REDOX REACTIVITY OF MODIFIED HEMOGLOBINS WITH HYDROGEN-PEROXIDE AND NITRIC-OXIDE - TOXICOLOGICAL IMPLICATIONS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 373-386
Authors:
ROTH RI
KACA W
Citation: Ri. Roth et W. Kaca, TOXICITY OF HEMOGLOBIN-SOLUTIONS - HEMOGLOBIN IS A LIPOPOLYSACCHARIDE(LPS) BINDING-PROTEIN WHICH ENHANCES LPS BIOLOGICAL-ACTIVITY, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 387-398
Authors:
PANTER SS
VANDEGRIFF KD
YAN PO
REGAN RF
Citation: Ss. Panter et al., ASSESSMENT OF HEMOGLOBIN-DEPENDENT NEUROTOXICITY - ALPHA-ALPHA CROSS-LINKED HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 399-413
Authors:
KLUGER R
JONES RT
SHIH DT
Citation: R. Kluger et al., CROSS-LINKING HEMOGLOBIN BY DESIGN - LESSONS FROM USING MOLECULAR CLAMPS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 415-428
Authors:
OLSON JS
Citation: Js. Olson, GENETIC-ENGINEERING OF MYOGLOBIN AS A SIMPLE PROTOTYPE FOR HEMOGLOBIN-BASED BLOOD SUBSTITUTES, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 429-441
Authors:
VANDEGRIFF KD
LETELLIER YC
Citation: Kd. Vandegriff et Yc. Letellier, A COMPARISON OF RATES OF HEME EXCHANGE - SITE-SPECIFICALLY CROSS-LINKED VERSUS POLYMERIZED HUMAN HEMOGLOBINS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 443-455
Authors:
SHOEMAKER SA
GERBER MJ
EVANS GL
ARCHERPAIK LE
SCOGGIN CH
Citation: Sa. Shoemaker et al., INITIAL CLINICAL-EXPERIENCE WITH A RATIONALLY DESIGNED, GENETICALLY-ENGINEERED RECOMBINANT HUMAN HEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 457-465